Specific compositions of amyloid-beta peptides as the determinant of toxic beta-aggregation.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Biological Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 12716908
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurodegenerative disease: Amyloid pores from pathogenic mutations

  2002cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

  2002cited by this paper
• Toxic Proteins in Neurodegenerative Disease

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.

  2001cited by this paper
• Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.

  2001cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.

  1999cited by this paper
• Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein

  1998cited by this paper
• Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

  1996cited by this paper
• An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

  1994cited by this paper
• Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution

  1993cited by this paper
• Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

  1993cited by this paper
• Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

  1992cited by this paper
• A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

  1992cited by this paper
• Framing beta-amyloid.

  1992cited by this paper
• Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β–amyloid precursor protein gene

  1992cited by this paper
• Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation.

  1991cited by this paper
• Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

  1991cited by this paper
• Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition.

  1991cited by this paper
• Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

  1990cited by this paper
• Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.

  1989cited by this paper
• Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro.

  1987cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Presenile dementia and Alzheimer's disease in mongolism.

  1969cited by this paper

• Evaluation of the Ability of Wasp Venom Bioinspired Peptides (Fraternine‐10 and Octovespin) in the Disaggregation and Anti‐Aggregation of Amyloid‐β Fibrils

  2025cites this paper
• Single-Molecule Characterization of Heterogeneous Oligomer Formation during Co-Aggregation of 40- and 42-Residue Amyloid-β.

  2024cites this paper
• Amyloid beta 1‐40 and 1‐42 fibril ratios and maturation level cause conformational differences with minimal impact on autophagy and cytotoxicity

  2024cites this paper
• Prediction of the Feasibility of Using the ≪Gold Standard≫ Thioflavin T to Detect Amyloid Fibril in Acidic Media.

  2024cites this paper
• Genomic stress and impaired DNA repair in Alzheimer disease.

  2024cites this paper
• Cerebral apolipoprotein E and amyloid precursor-like protein 1 as risk factors for chronic neurodegeneration after non-traumatic acute brain injury (ABI)

  2023cites this paper
• The Pathological Effects of Circulating Hydrophobic Bile Acids in Alzheimer’s Disease

  2023cites this paper
• Atomic zinc sites with hierarchical porous carbon for high-throughput chemical screening with high loading capacity and stability.

  2022cites this paper
• Influencing factors and characterization methods of nanoparticles regulating amyloid aggregation.

  2022cites this paper
• Involvement of calcium ions in amyloid-β-induced lamin fragmentation.

  2022cites this paper
• DNA Damage Increases Secreted Aβ40 and Aβ42 in Neuronal Progenitor Cells: Relevance to Alzheimer’s Disease

  2022cites this paper
• Journey on Naphthoquinone and Anthraquinone Derivatives: New Insights in Alzheimer’s Disease

  2021cites this paper
• Promising tacrine/huperzine A‐based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget

  2021cites this paper
• Mixing Aβ(1-40) and Aβ(1-42) peptides generates unique amyloid fibrils.

  2020cites this paper
• The New Application of UHPLC-DAD-TOF/MS in Identification of Inhibitors on β-Amyloid Fibrillation From Scutellaria baicalensis

  2019cites this paper
• Structure and Function of Alzheimer’s Amyloid βeta Proteins from Monomer to Fibrils: A Mini Review

  2019cites this paper
• Anticancer altretamine recognition by bovine serum albumin and its role as inhibitor of fibril formation: Biophysical insights.

  2019cites this paper
• Human Alzheimer’s disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology

  2018cites this paper
• Loss of canonical Wnt signaling is involved in the pathogenesis of Alzheimer's disease

  2018cites this paper
• Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration

  2018cites this paper
• Hetero-assembly of a dual β-amyloid variant peptide system.

  2018cites this paper
• Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20‐APP transgenic and wild‐type mice

  2018cites this paper
• In silico investigation on the inhibition of Aβ42 aggregation by Aβ40 peptide by potential of mean force study

  2018cites this paper
• The pro‐apoptotic protein Bmf co‐operates with Bim and Puma in neuron death induced by &bgr;‐amyloid or NGF deprivation☆

  2018cites this paper
• Amyloid β-peptides 1–40 and 1–42 form oligomers with mixed β-sheets

  2017cites this paper
• Selective inhibition of aggregation/fibrillation of bovine serum albumin by osmolytes: Mechanistic and energetics insights

  2017cites this paper
• Characterization and analysis of binding of Thioflavin T with partially folded and native states of α-lactalbumin protein by calorimetric and spectroscopic techniques.

  2017cites this paper
• Aggregation of alpha-synuclein using single-molecule spectroscopy

  2017cites this paper
• Quantitative analysis of co-oligomer formation by amyloid-beta peptide isoforms

  2016cites this paper
• Enhanced fluorescence of [[5'-(4-hydroxyphenyl)[2,2'-bithiophen]-5-yl]methylene]-propanedinitrile (NIAD-4): solvation induced micro-viscosity enhancement.

  2016cites this paper
• Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementias

  2016cites this paper
• Fine mapping of the Aβ oligomer binding site on PrP

  2016influential citation
• The blood clotting Factor XIIIa forms unique complexes with amyloid‐beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathy

  2016cites this paper
• Inhibition of Wnt signaling induces amyloidogenic processing of amyloid precursor protein and the production and aggregation of Amyloid‐β (Aβ)42 peptides

  2016influential citation
• Discriminative adsorption of amphiphilic monolayer protected gold nanoparticles on amyloid fibers

  2016cites this paper
• Late age increase in soluble amyloid-beta levels in the APP23 mouse model despite steady-state levels of amyloid-beta-producing proteins.

  2016cites this paper
• Recent Progress in the Identification of Non-Invasive Biomarkers to Support the Diagnosis of Alzheimer’s Disease in Clinical Practice and to Assist Human Clinical Trials

  2015cites this paper
• Intrinsically Disordered Proteins Studied by NMR Spectroscopy

  2015cites this paper
• Engineering of a peptide probe for β-amyloid aggregates.

  2015cites this paper
• Exogenous β-amyloid peptide interferes with GLUT4 localization in neurons.

  2015cites this paper
• Beta Amyloid Hallmarks: From Intrinsically Disordered Proteins to Alzheimer's Disease.

  2015cites this paper
• The Dependence of Amyloid-β Dynamics on Protein Force Fields and Water Models.

  2015cites this paper
• The Essential Role of p53-up-regulated Modulator of Apoptosis (Puma) and Its Regulation by FoxO3a Transcription Factor in β-Amyloid-induced Neuron Death*

  2014cites this paper
• Transient dynamics of Aβ contribute to toxicity in Alzheimer’s disease

  2014cites this paper
• Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques

  2014cites this paper
• A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer’s disease mice

  2014cites this paper
• Wild‐type, Flemish, and Dutch amyloid‐β exhibit different cytotoxicities depending on Aβ40 to Aβ42 interaction time and concentration ratio

  2013cites this paper
• Injection of specific amyloid-beta oligomers (beta1-40:beta1-42 = 10:1) into rat medial septum impairs memory retention without inducing hippocampal apoptosis

  2013cites this paper
• Treatment with D3 Removes Amyloid Deposits, Reduces Inflammation, and Improves Cognition in Aged AβPP/PS1 Double Transgenic Mice

  2013cites this paper
• Seeded strain‐like transmission of β‐amyloid morphotypes in APP transgenic mice

  2013cites this paper
• Diazoxide and cyclosporin A protect primary cholinergic neurons against beta-amyloid (1-42)-induced cytotoxicity

  2013cites this paper
• Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils

  2013cites this paper
• Signature Amyloid β Profiles Are Produced by Different γ-Secretase Complexes*

  2013cites this paper
• Monoclonal antibodies against large oval aggregates of Aβ1-42.

  2013cites this paper
• Modulation of amyloid-β 1-42 structure and toxicity by proline-rich whey peptides.

  2013cites this paper
• β-sheet propensity controls the kinetic pathways and morphologies of seeded peptide aggregation.

  2012cites this paper
• Modulation of beta-amyloid aggregation by engineering the sequence connecting beta-strand forming domains.

  2012cites this paper
• A peptide probe for detection of various beta-amyloid oligomers.

  2012cites this paper
• Xylocoside G Reduces Amyloid-β Induced Neurotoxicity by Inhibiting NF-κB Signaling Pathway in Neuronal Cells

  2012cites this paper
• Treatment with Aβ42 binding D-amino acid peptides reduce amyloid deposition and inflammation in APP/PS1 double transgenic mice.

  2012cites this paper
• Study on Protection Against β-Amyloid Peptide Toxicity With Oral Administration of Medicinal Herbs

  2012cites this paper
• β‐amyloid peptide is internalized into chick retinal neurons and alters the distribution of myosin Vb

  2012cites this paper
• Analysis of quality , aggregation and toxicity of amyloid beta peptide produced by JPT

  2011cites this paper
• Characterization of Oligomer Formation of Amyloid-β Peptide Using a Split-luciferase Complementation Assay*

  2011cites this paper
• Age-related brain pathology in Octodon degu: blood vessel, white matter and Alzheimer-like pathology.

  2011cites this paper
• Structural Basis for Increased Toxicity of Pathological Aβ42:Aβ40 Ratios in Alzheimer Disease*

  2011cites this paper
• Fluorescence Quantum Yield of Thioflavin T in Rigid Isotropic Solution and Incorporated into the Amyloid Fibrils

  2010cites this paper
• Charge transfer process determines ultrafast excited state deactivation of thioflavin T in low-viscosity solvents.

  2010cites this paper
• Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio

  2010cites this paper
• Increased Accumulation of Intraneuronal Amyloid β in HIV-Infected Patients

  2009cites this paper
• Glyceraldehyde-3-phosphate Dehydrogenase Aggregate Formation Participates in Oxidative Stress-induced Cell Death*

  2009cites this paper
• E22Q-mutant Abeta peptide (AbetaDutch) increases vascular but reduces parenchymal Abeta deposition.

  2009cites this paper
• Interactions of thioflavin T with serum albumins: spectroscopic analyses.

  2009cites this paper
• Cerebral amyloid angiopathy: a common cause of cerebral hemorrhage.

  2009cites this paper
• Short Communication E22Q-Mutant A (cid:1) Peptide (A (cid:1) Dutch) Increases Vascular but Reduces Parenchymal A (cid:1) Deposition

  2009cites this paper
• Amyloid-beta peptide Abetap3-42 affects early aggregation of full-length Abeta1-42.

  2009cites this paper
• Thioflavin T as a molecular rotor: fluorescent properties of thioflavin T in solvents with different viscosity.

  2008cites this paper
• Enzymatic characteristics of I213T mutant presenilin-1/gamma-secretase in cell models and knock-in mouse brains: familial Alzheimer disease-linked mutation impairs gamma-site cleavage of amyloid precursor protein C-terminal fragment beta.

  2008cites this paper
• Spatial memory impairment without apoptosis induced by the combination of beta-amyloid oligomers and cerebral ischemia is related to decreased acetylcholine release in rats.

  2008cites this paper
• Nanotechnology Solutions for Alzheimer's Disease: Advances in Research Tools, Diagnostic Methods and Therapeutic Agents

  2008cites this paper
• Computational study of thioflavin T torsional relaxation in the excited state.

  2007cites this paper
• Surface structure of amyloid-beta fibrils contributes to cytotoxicity.

  2007cites this paper
• Decreased Abeta secretion by cells expressing familial Alzheimer's disease-linked mutant presenilin 1.

  2007cites this paper
• Spectral properties of thioflavin T in solvents with different dielectric properties and in a fibril-incorporated form.

  2007cites this paper
• Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models.

  2006cites this paper
• Secretion of the Notch-1 Abeta-like peptide during Notch signaling.

  2006cites this paper
• Circular dichroism and aggregation studies of amyloid beta (11-8) fragment and its variants.

  2005cites this paper
• Independent heterologous fibrillation of insulin and its B-chain peptide.

  2005cites this paper
• Small peptides as treatments for Alzheimer’s disease Small peptides as treatments for Alzheimer’s disease

  year unknowncites this paper